Chemotherapy-induced anemia in adults: incidence and treatment.

@article{Groopman1999ChemotherapyinducedAI,
  title={Chemotherapy-induced anemia in adults: incidence and treatment.},
  author={Jerome E. Groopman and LorettaM. Itri},
  journal={Journal of the National Cancer Institute},
  year={1999},
  volume={91 19},
  pages={
          1616-34
        }
}
Anemia is a common complication of myelosuppressive chemotherapy that results in a decreased functional capacity and quality of life (QOL) for cancer patients. Severe anemia is treated with red blood cell transfusions, but mild-to-moderate anemia in patients receiving chemotherapy has traditionally been managed conservatively on the basis of the perception that it was clinically unimportant. This practice has been reflected in the relative inattention to standardized and complete reporting of… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 320 CITATIONS, ESTIMATED 48% COVERAGE

Epoetin beta for the treatment of chemotherapy-induced anemia: an update

  • OncoTargets and therapy
  • 2015
VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Extended-dosage-interval regimens of erythropoietic agents in chemotherapy-induced anemia.

  • American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
  • 2007
VIEW 7 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Impact of erythropoiesis-stimulating agents on red blood cell transfusion in Korea

  • International Journal of Clinical Pharmacy
  • 2012
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

MANAGING PATIENTS WITH CHEMOTHERAPY-INDUCED ANEMIA

VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2000
2019

CITATION STATISTICS

  • 18 Highly Influenced Citations

  • Averaged 17 Citations per year from 2017 through 2019

Similar Papers

Loading similar papers…